COVID-19 took serious toll on Native Hawaiian/Pacific Islander mental and physical health

Two UC Riverside-led studies found concerning psychological and physical health problems among more than 300 NH/PIs in five US states

By Iqbal Pittalwala | | Health

A shot in the arm

UC Riverside experts answer questions on Americans needing just one COVID-19 booster vaccine each year

By Iqbal Pittalwala | | Health

Monkeypox explained

UC Riverside experts discuss disease symptoms, vaccines, and anxiety management

By Iqbal Pittalwala | | Health

New pathway facilitates community college students joining UC Riverside medical school

The School of Medicine at the University of California, Riverside, has received a grant of $1.87 million to establish the Inland Empire Regional Hub for Healthcare Opportunity, or IE RHHO, which will create a pre-med pathway for local community college students. The four-year grant funding is provided by the California...

By Iqbal Pittalwala | | Health

COVID-19 vaccines for very young children

UC Riverside vaccine expert David Lo shares his thoughts in a Q&A

Riverside clinic to address healthcare needs of the homeless

UniHealth Foundation grant to UC Riverside aims to increase the health and well-being of the unhoused population in Riverside County

By Iqbal Pittalwala | | Health

Marginalized communities of color face high COVID-19 risk

UC Riverside study focused on farm-working communities in California’s Eastern Coachella Valley

By Iqbal Pittalwala | | Health

Is there still a benefit to masking?

UC Riverside epidemiologist weighs in on how protective your mask is when nobody around you is masked

By Iqbal Pittalwala | | Health

To mask, or not to mask?

To gauge whether scientists agree with popular sentiment around mask wearing, we check in here with three UC Riverside virologists and epidemiologists.

By Jules Bernstein | | Health

UCR biomedical scientist joins international SARS-CoV-2 group assembled by NIAID

SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants

By Iqbal Pittalwala | | Health

Experts urge reconsideration of 'standard' for time-keeping

To gauge the impacts of dark mornings in some parts of the country, we spoke with two UC Riverside experts

Should you get a second booster shot for COVID-19?

UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts

By Iqbal Pittalwala | | Health

UC Riverside program for high school students aims to diversify STEM workforce

Underrepresented students will participate in carefully designed summer research and educational activities at UC Riverside

By Holly Ober | | Science / Technology

A potential antiviral for SARS and SARS-like coronaviruses

UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed

By Iqbal Pittalwala | | Health

Scientists profile FDA-approved drugs to potentially treat hundreds of genetic disorders

New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders

By Iqbal Pittalwala | | Health

Researchers develop molecular traps to target SARS-CoV-2

Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells

By Iqbal Pittalwala | | Health

Scientists discover new avian immunological pathway

UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines

By Iqbal Pittalwala | | Health

Building robust collaborations to ‘ATTACK’ future pandemics

As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...

By UCR News | | Health

Is it time to wear a highly efficient medical grade facemask?

UC Riverside experts weigh in

By Iqbal Pittalwala | | Health

A more targeted therapy to treat inflammatory bowel disease

UC Riverside mouse study focuses on the receptor TNFR1

By Iqbal Pittalwala | | Health